What the Upcoming Earnings Report Could Mean for Copart (CPRT)

Analysts expect Copart (CPRT) to report its fourth quarter results soon, with projections pointing to a single digit earnings decline. Recent quarters have mostly topped forecasts, although one miss and concerns around insurance auction volumes and logistics costs continue to shape sentiment.

Copart's recent trading reflects mixed momentum, with a 1 day share price return of 6.62% and a 7 day share price return of 8.37%, set against a 90 day share price return that is down 10.65% and a 1 year total shareholder return that has declined 35.35%. This suggests that short term optimism around the upcoming results contrasts with a weaker longer term experience for shareholders.

If Copart's recent swing has you thinking about where else capital is moving, this could be a useful moment to broaden your search and check out 18 top founder-led companies

The recent rebound in Copart after a weak year for returns puts you at a crossroads. You can either lean into the current reset or wait for an even cheaper entry. The valuation picture is the place to start.

Most Popular Narrative: 39.2% Undervalued

Copart's most followed valuation narrative puts fair value at $49.00 a share, compared with the recent close at $29.79. That gap is what the upcoming earnings report will sit on top of.

The market appears to be treating slower growth as evidence that the moat has weakened. I do not think the evidence supports that yet. The US business has stalled. But the international business is growing. Margins remain powerful. The balance sheet remains strong. The network effects remain intact.

The key to this Copart narrative is how strong margins, international expansion and a specific earnings path are combined with a particular future valuation multiple. If you are curious which assumptions really carry the weight here, the detailed narrative lays out the full playbook.

Result: Fair Value of $49.00 (UNDERVALUED)

However, Copart’s narrative can break if US demand stays soft or if international growth slows, since both would challenge the idea that the moat is still compounding.

Next Steps

If the mix of concern and optimism around Copart leaves you undecided, now is a good time to review the underlying data and decide where you stand. To see what is driving the more optimistic views in the market, take a closer look at 4 key rewards

Looking for more investment ideas beyond Copart?

If Copart has sharpened your focus on where capital could work harder, do not stop here. Use the Simply Wall Street Screener to spot what others might miss.

• Target reliable compounding income and see which companies stand out as potential 8 dividend fortresses for investors who want yield with substance.
• Hunt for quality at a reasonable price by screening for 51 high quality undervalued stocks that may offer stronger fundamentals than their current market pricing suggests.
• Secure your downside first and focus on resilience with the 84 resilient stocks with low risk scores that prioritize sturdier business profiles and reduced volatility.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.